Synergistic Effect of Stauntonia hexaphylla (Thunb.) Decne Fruit and Leaf on RAW 264.7 Osteoclast and MC3T3-E1 Osteoblast Differentiation
Open Access
- 10 June 2025
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 15 (6) , 844
Abstract
Stauntonia hexaphylla (Thunb.) Decne (SH) is known for its anti-inflammatory, analgesic, antioxidant, and anti-osteoporotic properties. This study investigated the composition of SH leaves and fruits and assessed their individual and combined effects in an in vitro osteoporosis model. Extracts with varying leaf-to-fruit ratios (SH82, SH55, SH28) were evaluated in MC3T3-E1 and RAW264.7 cells to examine osteogenesis and bone resorption biomarkers. SH leaves were rich in chlorogenic acids (CGAs) and flavonoids, while fruits contained phenolic acids with minimal flavonoids. Leaf extracts exhibited superior antioxidant activity and ROS suppression. Both leaf and fruit extracts enhanced ALP activity, calcium deposition, and collagen formation in MC3T3-E1 cells, with leaf extracts demonstrating greater efficacy. Additionally, osteoblastogenesis-related genes were upregulated, while TRAP activity and osteoclast-related gene expression were significantly inhibited. The combined extract exerted a synergistic effect, with SH28 showing the most pronounced osteogenic enhancement and TRAP inhibition. Key components, including neo-CGA, CGA, rutin, and luteolin-7-O-glucoside, positively influenced ALP and TRAP activities. These findings highlight the potential of SH, particularly at a high leaf-to-fruit ratio, as a promising natural agent for osteoporosis prevention.Keywords
Funding Information
- R&D Project for development of health functional foods, Ministry of SMEs and Startups, Republic of Korea (RS-2022-00167225)
This publication has 33 references indexed in Scilit:
- Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trialsJournal of Traditional and Complementary Medicine, 2023
- Pterostilbene-isothiocyanate impedes RANK/TRAF6 interaction to inhibit osteoclastogenesis, promoting osteogenesis in vitro and alleviating glucocorticoid induced osteoporosis in ratsBiochemical Pharmacology, 2022
- Mechanical regulation of bone remodelingBone Research, 2022
- Network Pharmacology-Based Analysis on the Action Mechanism of Oleanolic Acid to Alleviate OsteoporosisACS Omega, 2021
- Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylationsNature Communications, 2020
- Bioactive triterpene glycosides from the fruit of Stauntonia hexaphylla and insights into the molecular mechanism of its inflammatory effectsBioorganic & Medicinal Chemistry Letters, 2019
- Isolation, structural elucidation, and insights into the anti-inflammatory effects of triterpene saponins from the leaves of Stauntonia hexaphyllaBioorganic & Medicinal Chemistry Letters, 2019
- Phospholipase D: A new mediator during high phosphate‐induced vascular calcification associated with chronic kidney diseaseJournal of Cellular Physiology, 2018
- Caveolin-1 regulates osteoclast differentiation by suppressing cFms degradationExperimental & Molecular Medicine, 2015
- RANKL/OPG; Critical role in bone physiologyReviews in Endocrine and Metabolic Disorders, 2015